Massmutual Trust Co. FSB ADV bought a new position in JPMorgan US Value Factor ETF (NYSEARCA:JVAL – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 997 shares of the company’s stock, valued at approximately $41,000.
A number of other hedge funds have also bought and sold shares of JVAL. ICA Group Wealth Management LLC purchased a new position in JPMorgan US Value Factor ETF in the 4th quarter worth about $44,000. Addison Advisors LLC raised its position in JPMorgan US Value Factor ETF by 1,209.1% in the 4th quarter. Addison Advisors LLC now owns 4,320 shares of the company’s stock worth $167,000 after buying an additional 3,990 shares during the last quarter. Good Life Advisors LLC purchased a new position in JPMorgan US Value Factor ETF in the 4th quarter worth about $200,000. Snider Financial Group purchased a new position in JPMorgan US Value Factor ETF in the 4th quarter worth about $209,000. Finally, Avaii Wealth Management LLC purchased a new position in JPMorgan US Value Factor ETF in the 4th quarter worth about $210,000.
JPMorgan US Value Factor ETF Stock Up 0.2 %
NYSEARCA JVAL opened at $41.07 on Friday. JPMorgan US Value Factor ETF has a 52 week low of $32.76 and a 52 week high of $41.73. The firm has a market capitalization of $815.24 million, a P/E ratio of 15.29 and a beta of 0.99. The company has a 50-day moving average price of $40.50 and a 200-day moving average price of $39.73.
JPMorgan US Value Factor ETF Company Profile
The JPMorgan U.S. Value Factor ETF (JVAL) is an exchange-traded fund that is based on the JP Morgan US Value Factor index. The fund tracks an index of large-cap US equities that are selected and weighted by four relative valuation factors: book yield, earnings yield, dividend yield and cash flow yield.
Featured Stories
- Five stocks we like better than JPMorgan US Value Factor ETF
- Conference Calls and Individual Investors
- McDonald’s Stock: Balancing Value and Innovation
- How to Find Undervalued Stocks
- MarketBeat Week in Review – 6/17 – 6/21
- Stock Market Sectors: What Are They and How Many Are There?
- Sarepta Therapeutics Stock Soars on FDA Approval
Want to see what other hedge funds are holding JVAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan US Value Factor ETF (NYSEARCA:JVAL – Free Report).
Receive News & Ratings for JPMorgan US Value Factor ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan US Value Factor ETF and related companies with MarketBeat.com's FREE daily email newsletter.